XENETIC BIOSCIENCES, INC. Cash Divested from Deconsolidation
XENETIC BIOSCIENCES, INC. (XBIO) reported Cash Divested from Deconsolidation of $0 for the 12-month period ending 2015-12-31, per its 10-K filed 2016-03-30.
Discontinued › Cash Flow › Cash
us-gaap:CashDivestedFromDeconsolidation · last filed 2016-03-30
- XENETIC BIOSCIENCES, INC. cash divested from deconsolidation for the quarter ending 2015-12-31 was $0.00.
- XENETIC BIOSCIENCES, INC. cash divested from deconsolidation for the quarter ending 2015-09-30 was $0.00.
- XENETIC BIOSCIENCES, INC. cash divested from deconsolidation for the quarter ending 2015-06-30 was $0.00.
- XENETIC BIOSCIENCES, INC. cash divested from deconsolidation for the quarter ending 2015-03-31 was $0.00, a 100.00% decline year-over-year.
- XENETIC BIOSCIENCES, INC. cash divested from deconsolidation for fiscal 2015 was $0.00, a 100.00% decline from fiscal 2014.
- XENETIC BIOSCIENCES, INC. cash divested from deconsolidation for fiscal 2014 was $43.50K.
- XENETIC BIOSCIENCES, INC. cash divested from deconsolidation for fiscal 2013 was $0.00.
| Period end | Cash Divested from Deconsolidation 3 month | Cash Divested from Deconsolidation 6 month | Cash Divested from Deconsolidation 9 month | Cash Divested from Deconsolidation 12 month |
|---|---|---|---|---|
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | $0.00 derived: sum of 2 quarters · filed 2016-03-30 | $0.00 derived: sum of 3 quarters · filed 2016-03-30 | $0.00 10-K · filed 2016-03-30 |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-16 | $0.00 derived: sum of 2 quarters · filed 2015-11-16 | $0.00 10-Q · filed 2015-11-16 | $0.00 derived: sum of 4 quarters · filed 2016-03-30 |
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-19 | $0.00 10-Q · filed 2015-08-19 | $0.00 derived: sum of 3 quarters · filed 2016-03-30 | $0.00 derived: sum of 4 quarters · filed 2016-03-30 |
| 2015-03-31 | $0.00 10-Q · filed 2015-05-20 | $0.00 derived: sum of 2 quarters · filed 2016-03-30 | $0.00 derived: sum of 3 quarters · filed 2016-03-30 | $0.00 derived: sum of 4 quarters · filed 2016-03-30 |
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | $0.00 derived: sum of 2 quarters · filed 2016-03-30 | $0.00 derived: sum of 3 quarters · filed 2016-03-30 | $43.50K 10-K · filed 2016-03-30 |
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-16 | $0.00 derived: sum of 2 quarters · filed 2015-11-16 | $43.50K 10-Q · filed 2015-11-16 | |
| 2014-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-19 | $43.50K 10-Q · filed 2015-08-19 | ||
| 2014-03-31 | $43.50K 10-Q · filed 2015-05-20 | |||
| 2013-12-31 | $0.00 10-K · filed 2015-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |